• Sarepta Therapeutics average debt/equity ratio for 2023 was 1.59, a 38.85% decline from 2022.
• Sarepta Therapeutics average debt/equity ratio for 2022 was 2.6, a 33.33% decline from 2021.
• Sarepta Therapeutics average debt/equity ratio for 2021 was 1.95, a 132.14% increase from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.